— Know what they know.
Not Investment Advice

COLL NASDAQ

Collegium Pharmaceutical, Inc.
1W: -1.2% 1M: +4.1% 3M: -23.5% YTD: -24.4% 1Y: +14.9% 3Y: +49.5% 5Y: +50.9%
$34.07
-0.35 (-1.02%)
 
Weekly Expected Move ±6.5%
$29 $32 $34 $36 $38
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 50 · $1.1B mcap · 32M float · 1.71% daily turnover · Short 57% of daily vol

📊 Key Metrics

TTM
$796M
Revenue
+19.9% YoY
$75M
Net Income
+70.7% YoY
$330M
Free Cash Flow
+67.8% YoY
60.6%
Gross Margin
16.5%
Op. Margin
7.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE28.3%
ROA4.5%
ROIC15.7%

Valuation

P/E14.6
P/B3.5
EV/EBITDA3.1

Leverage

Debt/Equity3.12
Current Ratio1.57
Interest Cov.1.6x

Quality Scores

Piotroski F7/9
Altman Z1.70
Beneish M-3.22

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms